Log in
NASDAQ:DARE

Daré Bioscience News Headlines

$1.33
+0.03 (+2.31 %)
(As of 11/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.21
Now: $1.33
$1.34
50-Day Range
$0.96
MA: $1.06
$1.32
52-Week Range
$0.75
Now: $1.33
$2.22
Volume1.21 million shs
Average Volume961,007 shs
Market Capitalization$50.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94

Headlines

Daré Bioscience (NASDAQ DARE) News Headlines Today

Source:
SourceHeadline
-$0.13 Earnings Per Share Expected for Daré Bioscience, Inc. (NASDAQ:DARE) This Quarter-$0.13 Earnings Per Share Expected for Daré Bioscience, Inc. (NASDAQ:DARE) This Quarter
americanbankingnews.com - November 24 at 3:53 PM
Daré Bioscience (NASDAQ:DARE) Shares Up 12.8%Daré Bioscience (NASDAQ:DARE) Shares Up 12.8%
americanbankingnews.com - November 18 at 6:36 PM
Daré Bioscience (NASDAQ:DARE) Posts  Earnings Results, Misses Expectations By $0.07 EPSDaré Bioscience (NASDAQ:DARE) Posts Earnings Results, Misses Expectations By $0.07 EPS
americanbankingnews.com - November 17 at 9:51 AM
Daré Bioscience, Inc. (NASDAQ:DARE) Short Interest UpdateDaré Bioscience, Inc. (NASDAQ:DARE) Short Interest Update
americanbankingnews.com - November 16 at 4:40 AM
Daré Bioscience, Inc. (NASDAQ:DARE) Given Consensus Recommendation of "Hold" by BrokeragesDaré Bioscience, Inc. (NASDAQ:DARE) Given Consensus Recommendation of "Hold" by Brokerages
americanbankingnews.com - November 14 at 5:51 AM
Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average of $1.03Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average of $1.03
americanbankingnews.com - November 14 at 2:50 AM
Dare Bioscience shares are trading lower after the company reported worse-than-expected Q3 EPS results.Dare Bioscience shares are trading lower after the company reported worse-than-expected Q3 EPS results.
benzinga.com - November 13 at 7:03 PM
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2020 Results - Earnings Call TranscriptDaré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 1:14 AM
Dare Bioscience EPS misses by $0.06Dare Bioscience EPS misses by $0.06
seekingalpha.com - November 12 at 10:14 AM
Recap: Dare Bioscience Q3 EarningsRecap: Dare Bioscience Q3 Earnings
benzinga.com - November 12 at 10:14 AM
Daré Bioscience Reports Third Quarter 2020 Financial Results and Provides Company UpdateDaré Bioscience Reports Third Quarter 2020 Financial Results and Provides Company Update
finance.yahoo.com - November 12 at 10:14 AM
Dare Bioscience (DARE) to Release Earnings on ThursdayDare Bioscience (DARE) to Release Earnings on Thursday
americanbankingnews.com - November 6 at 1:50 PM
Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12, 2020Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12, 2020
finance.yahoo.com - November 5 at 12:24 PM
 Analysts Anticipate Dare Bioscience Inc (NASDAQ:DARE) Will Announce Earnings of -$0.15 Per Share Analysts Anticipate Dare Bioscience Inc (NASDAQ:DARE) Will Announce Earnings of -$0.15 Per Share
americanbankingnews.com - November 1 at 1:08 AM
Daré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Darés Novel Pipeline of Womens Health ProgramsDaré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Daré's Novel Pipeline of Women's Health Programs
benzinga.com - September 25 at 5:47 PM
Daré Bioscience receives funding from Bill & Melinda Gates FoundationDaré Bioscience receives funding from Bill & Melinda Gates Foundation
seekingalpha.com - September 21 at 3:48 PM
Daré Bioscience Receives $0.9 million Under the Current Grant Supplement Award for Continued Development of its User-Controlled, Long Acting Reversible Contraceptive (DARE-LARC1)Daré Bioscience Receives $0.9 million Under the Current Grant Supplement Award for Continued Development of its User-Controlled, Long Acting Reversible Contraceptive (DARE-LARC1)
finance.yahoo.com - September 21 at 10:47 AM
Dare Bioscience: Preparing For The Upcoming Phase 3 ResultsDare Bioscience: Preparing For The Upcoming Phase 3 Results
seekingalpha.com - September 16 at 3:41 PM
Daré Bioscience Announces Participation in Two Upcoming Virtual ConferencesDaré Bioscience Announces Participation in Two Upcoming Virtual Conferences
finance.yahoo.com - September 8 at 8:15 AM
Daré Bioscience engages Avomeen for product development servicesDaré Bioscience engages Avomeen for product development services
seekingalpha.com - September 1 at 1:31 PM
Daré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health ProgramsDaré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
finance.yahoo.com - September 1 at 8:29 AM
Daré Bioscience Announces Publication of DARE-BV1 Proof of Concept Study for the Treatment of Bacterial VaginosisDaré Bioscience Announces Publication of DARE-BV1 Proof of Concept Study for the Treatment of Bacterial Vaginosis
finance.yahoo.com - August 20 at 12:49 PM
Daré Bioscience receives ~$2.3M funding from NIH to support DARE-FRT1Daré Bioscience receives ~$2.3M funding from NIH to support DARE-FRT1
seekingalpha.com - August 19 at 2:59 PM
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-FRT1 Phase 1 Human Clinical Study for the Prevention of Preterm BirthDaré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-FRT1 Phase 1 Human Clinical Study for the Prevention of Preterm Birth
finance.yahoo.com - August 19 at 9:59 AM
Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12,Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12,
bloomberg.com - August 13 at 12:16 AM
Dare Bioscience EPS misses by $0.10Dare Bioscience EPS misses by $0.10
seekingalpha.com - August 12 at 9:05 AM
Daré Bioscience CEO to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual ConferenceDaré Bioscience CEO to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
finance.yahoo.com - August 6 at 11:14 AM
Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12, 2020Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12, 2020
finance.yahoo.com - August 5 at 9:49 AM
DARE.OQ - Dare Bioscience Inc Profile | ReutersDARE.OQ - Dare Bioscience Inc Profile | Reuters
www.reuters.com - July 30 at 5:47 PM
Daré Bioscience launches study of hormone therapy for menopausal symptomsDaré Bioscience launches study of hormone therapy for menopausal symptoms
seekingalpha.com - July 27 at 7:06 PM
Daré Bioscience Announces Initiation of Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-oral, Bio-identical Hormone Therapy for the Treatment of Menopausal SymptomsDaré Bioscience Announces Initiation of Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-oral, Bio-identical Hormone Therapy for the Treatment of Menopausal Symptoms
finance.yahoo.com - July 27 at 9:01 AM
774,000 workers recruitment: FG, N’Assembly flex muscles, federal lawmakers dare Buhari774,000 workers recruitment: FG, N’Assembly flex muscles, federal lawmakers dare Buhari
www.msn.com - July 1 at 11:35 PM
BRIEF-Daré Bioscience Announces Initiation Of Pivotal Phase 3 Study Of DARE-BV1BRIEF-Daré Bioscience Announces Initiation Of Pivotal Phase 3 Study Of DARE-BV1
www.reuters.com - June 18 at 12:26 AM
Daré Bioscience launches late-stage study of lead candidate in bacterial inflammationDaré Bioscience launches late-stage study of lead candidate in bacterial inflammation
seekingalpha.com - June 17 at 9:24 AM
Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial VaginosisDaré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis
finance.yahoo.com - June 17 at 9:23 AM
Daré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible ContraceptiveDaré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive
finance.yahoo.com - June 15 at 9:14 AM
BRIEF-Dare Bioscience Files Prospectus Related To Possible Resale Of Up To 5 Million Shares Of Common Stock By Selling StockholdersBRIEF-Dare Bioscience Files Prospectus Related To Possible Resale Of Up To 5 Million Shares Of Common Stock By Selling Stockholders
www.reuters.com - June 8 at 6:51 PM
Daré Bioscience Announces Participation in BIO Digital 2020Daré Bioscience Announces Participation in BIO Digital 2020
finance.yahoo.com - June 4 at 10:02 AM
BRIEF-Dare Bioscience Files Prospectus Supplement Related To Offering Of 7.5 Mln Shares Of Common StockBRIEF-Dare Bioscience Files Prospectus Supplement Related To Offering Of 7.5 Mln Shares Of Common Stock
www.reuters.com - May 20 at 8:26 AM
BRIEF-Dare Bioscience Files Prospectus Relates To Possible Resale Of Up To 5 Million Shares By Selling StockholdersBRIEF-Dare Bioscience Files Prospectus Relates To Possible Resale Of Up To 5 Million Shares By Selling Stockholders
www.reuters.com - May 15 at 6:25 PM
Edited Transcript of DARE earnings conference call or presentation 14-May-20 8:30pm GMTEdited Transcript of DARE earnings conference call or presentation 14-May-20 8:30pm GMT
finance.yahoo.com - May 15 at 8:07 AM
BRIEF-Dare Bioscience Reports Qtrly Loss Per Share $0.18BRIEF-Dare Bioscience Reports Qtrly Loss Per Share $0.18
www.reuters.com - May 14 at 10:56 PM
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2020 Results - Earnings Call TranscriptDaré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 10:56 PM
Daré Bioscience Reports First Quarter 2020 Financial Results and Provides Company UpdateDaré Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update
finance.yahoo.com - May 14 at 12:55 PM
Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Darés Novel Pipeline of Womens Health ProgramsDaré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré's Novel Pipeline of Women's Health Programs
www.benzinga.com - May 11 at 9:15 AM
BRIEF-Daré Bioscience And Health Decisions Form Strategic PartnershipBRIEF-Daré Bioscience And Health Decisions Form Strategic Partnership
www.reuters.com - May 11 at 9:15 AM
Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health ProgramsDaré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
finance.yahoo.com - May 11 at 9:14 AM
Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020
finance.yahoo.com - May 7 at 8:21 AM
Daré Bioscience files for 7.5M common sharesDaré Bioscience files for 7.5M common shares
seekingalpha.com - May 2 at 8:01 AM
BRIEF-Dare Bioscience Inc Files For Offer And Sale Of Up To 7.5 Million Shares Of Common Stock By Selling Stockholder - SEC FilingBRIEF-Dare Bioscience Inc Files For Offer And Sale Of Up To 7.5 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
www.reuters.com - May 1 at 10:00 PM
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.